Upregulation of CTNN-β1 and PLVAP was not evident in the colon and was not significant in the caecum, suggesting degradation along the gut of the bioactive molecules of BC stimulating their modulation or indirectly by a different impact of BC supplementation on the microbiota composition. The gene discussed is CTNNB1; the disease is breast cancer.